
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $246.3M | $328.3M | $454.8M | $461.1M | $556.6M | |
Revenue Growth (YoY) | 8.22% | 33.28% | 38.53% | 1.39% | 20.71% | |
Cost of Revenues | $60.7M | $70.4M | $107.6M | $103.4M | $110.1M | |
Gross Profit | $185.6M | $257.9M | $347.2M | $357.7M | $446.5M | |
Gross Profit Margin | 75.34% | 78.56% | 76.35% | 77.57% | 80.22% | |
R&D Expenses | $139.8M | $135.7M | $158.8M | $156.8M | $162.9M | |
Selling, General & Admin | $86.4M | $91.1M | $106.7M | $108.1M | $104.1M | |
Other Inc / (Exp) | -$2.3M | -$5.7M | -$93.8M | $85.8M | $4M | |
Operating Expenses | $227.3M | $228M | $267.2M | $266.2M | $267.5M | |
Operating Income | -$41.8M | $29.9M | $80.1M | $91.5M | $179M | |
Net Interest Expenses | -- | $995K | -- | -- | -- | |
EBT. Incl. Unusual Items | -$36.5M | $23.3M | -$7.8M | $187.2M | $200M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $3.9M | $5M | $6.5M | -$146.7M | $20.2M | |
Net Income to Company | -$40.5M | $18.3M | -$14.3M | $333.9M | $179.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$40.5M | $18.3M | -$14.3M | $333.9M | $179.8M | |
Basic EPS (Cont. Ops) | -$0.36 | $0.17 | -$0.13 | $3.09 | $1.67 | |
Diluted EPS (Cont. Ops) | -$0.36 | $0.16 | -$0.13 | $3.01 | $1.65 | |
Weighted Average Basic Share | $113.3M | $110.5M | $109.5M | $108.2M | $107.4M | |
Weighted Average Diluted Share | $113.3M | $114.9M | $109.5M | $110.9M | $109M | |
EBITDA | $22M | $78.3M | $41.2M | $237.1M | $244.1M | |
EBIT | -$26.2M | $34M | -$6M | $188.7M | $201.5M | |
Revenue (Reported) | $246.3M | $328.3M | $454.8M | $461.1M | $556.6M | |
Operating Income (Reported) | -$41.8M | $29.9M | $80.1M | $91.5M | $179M | |
Operating Income (Adjusted) | -$26.2M | $34M | -$6M | $188.7M | $201.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $70.4M | $99.1M | $113.8M | $117.9M | $166.7M | |
Revenue Growth (YoY) | 7% | 40.73% | 14.85% | 3.61% | 41.4% | |
Cost of Revenues | $17.4M | $22.4M | $31.7M | $23.7M | $32.8M | |
Gross Profit | $53M | $76.7M | $82.1M | $94.2M | $133.8M | |
Gross Profit Margin | 75.35% | 77.39% | 72.16% | 79.93% | 80.3% | |
R&D Expenses | $32.4M | $39.8M | $41.9M | $37.4M | $42.6M | |
Selling, General & Admin | $23.6M | $26.9M | $31M | $25.8M | $28M | |
Other Inc / (Exp) | -$368K | -$76M | -$7.1M | -$700K | -- | |
Operating Expenses | $56.2M | $67.1M | $73.3M | $63.4M | $70.6M | |
Operating Income | -$3.2M | $9.5M | $8.8M | $30.9M | $63.2M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$3.1M | -$65.7M | $3.5M | $34.4M | $67.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$503K | $514K | $201K | $1.5M | $7.3M | |
Net Income to Company | -$2.6M | -$66.2M | $3.3M | $32.9M | $60.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$2.6M | -$66.2M | $3.3M | $32.9M | $60.3M | |
Basic EPS (Cont. Ops) | -$0.02 | -$0.60 | $0.03 | $0.30 | $0.56 | |
Diluted EPS (Cont. Ops) | -$0.02 | -$0.60 | $0.03 | $0.30 | $0.56 | |
Weighted Average Basic Share | $112.2M | $109.9M | $108.3M | $108.1M | $107.2M | |
Weighted Average Diluted Share | $112.2M | $109.9M | $111.2M | $110M | $108.6M | |
EBITDA | $10.3M | -$54.3M | $16.7M | $45.7M | $77.8M | |
EBIT | -$502K | -$65.1M | $3.9M | $34.7M | $68M | |
Revenue (Reported) | $70.4M | $99.1M | $113.8M | $117.9M | $166.7M | |
Operating Income (Reported) | -$3.2M | $9.5M | $8.8M | $30.9M | $63.2M | |
Operating Income (Adjusted) | -$502K | -$65.1M | $3.9M | $34.7M | $68M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $250.9M | $357M | $469.5M | $465.2M | $605.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $62.2M | $75.4M | $116.9M | $95.4M | $119.3M | |
Gross Profit | $188.7M | $281.5M | $352.6M | $369.8M | $486.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $135.5M | $143.1M | $160.9M | $152.3M | $168.1M | |
Selling, General & Admin | $86.7M | $94.4M | $110.8M | $102.9M | $106.3M | |
Other Inc / (Exp) | -$3.6M | -$81.3M | -$24.9M | $92.3M | $4.7M | |
Operating Expenses | $223.2M | $238.9M | $273.3M | $256.3M | $274.7M | |
Operating Income | -$34.5M | $42.6M | $79.3M | $113.6M | $211.4M | |
Net Interest Expenses | -- | $607K | -- | -- | -- | |
EBT. Incl. Unusual Items | -$34.1M | -$39.3M | $61.4M | $218M | $233.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.5M | $6M | $6.2M | -$145.5M | $26.1M | |
Net Income to Company | -$36.5M | -$45.3M | $55.2M | $363.5M | $207.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$36.5M | -$45.3M | $55.2M | $363.5M | $207.2M | |
Basic EPS (Cont. Ops) | -$0.32 | -$0.41 | $0.51 | $3.34 | $1.92 | |
Diluted EPS (Cont. Ops) | -$0.32 | -$0.42 | $0.49 | $3.27 | $1.92 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $22.9M | $13.7M | $112.1M | $266.1M | $276.3M | |
EBIT | -$23.7M | -$30.6M | $63M | $219.5M | $234.7M | |
Revenue (Reported) | $250.9M | $357M | $469.5M | $465.2M | $605.4M | |
Operating Income (Reported) | -$34.5M | $42.6M | $79.3M | $113.6M | $211.4M | |
Operating Income (Adjusted) | -$23.7M | -$30.6M | $63M | $219.5M | $234.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $70.4M | $99.1M | $113.8M | $117.9M | $166.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $17.4M | $22.4M | $31.7M | $23.7M | $32.8M | |
Gross Profit | $53M | $76.7M | $82.1M | $94.2M | $133.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $32.4M | $39.8M | $41.9M | $37.4M | $42.6M | |
Selling, General & Admin | $23.6M | $26.9M | $31M | $25.8M | $28M | |
Other Inc / (Exp) | -$368K | -$76M | -$7.1M | -$700K | -- | |
Operating Expenses | $56.2M | $67.1M | $73.3M | $63.4M | $70.6M | |
Operating Income | -$3.2M | $9.5M | $8.8M | $30.9M | $63.2M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$3.1M | -$65.7M | $3.5M | $34.4M | $67.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$503K | $514K | $201K | $1.5M | $7.3M | |
Net Income to Company | -$2.6M | -$66.2M | $3.3M | $32.9M | $60.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$2.6M | -$66.2M | $3.3M | $32.9M | $60.3M | |
Basic EPS (Cont. Ops) | -$0.02 | -$0.60 | $0.03 | $0.30 | $0.56 | |
Diluted EPS (Cont. Ops) | -$0.02 | -$0.60 | $0.03 | $0.30 | $0.56 | |
Weighted Average Basic Share | $112.2M | $109.9M | $108.3M | $108.1M | $107.2M | |
Weighted Average Diluted Share | $112.2M | $109.9M | $111.2M | $110M | $108.6M | |
EBITDA | $10.3M | -$54.3M | $16.7M | $45.7M | $77.8M | |
EBIT | -$502K | -$65.1M | $3.9M | $34.7M | $68M | |
Revenue (Reported) | $70.4M | $99.1M | $113.8M | $117.9M | $166.7M | |
Operating Income (Reported) | -$3.2M | $9.5M | $8.8M | $30.9M | $63.2M | |
Operating Income (Adjusted) | -$502K | -$65.1M | $3.9M | $34.7M | $68M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $129M | $107.9M | $125.3M | $94.8M | $99.8M | |
Short Term Investments | $373.7M | $377.7M | $187.9M | $331.1M | $382M | |
Accounts Receivable, Net | $27.9M | $44.1M | $55.4M | $82.9M | $122.8M | |
Inventory | $14.5M | $8.5M | $20.9M | $36.2M | $44.6M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $15.9M | $10.6M | $12M | $34.9M | $15.9M | |
Total Current Assets | $699.7M | $684.4M | $527.2M | $630.6M | $690.3M | |
Property Plant And Equipment | $86.4M | $79.7M | $110.4M | $89.3M | $97M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $183.2M | $278.8M | $292M | $286.8M | $286.8M | |
Other Intangibles | $36.5M | $58.4M | $50.9M | $28.8M | $17.1M | |
Other Long-Term Assets | $4.5M | $4.2M | $2.7M | $6M | $5.6M | |
Total Assets | $1.3B | $1.2B | $1B | $1.3B | $1.3B | |
Accounts Payable | $9M | $11.3M | $24.8M | $18.1M | $18.5M | |
Accrued Expenses | $23.3M | $20.9M | $20.5M | $17.5M | $19.2M | |
Current Portion Of Long-Term Debt | -- | $163.7M | $10.4M | -- | -- | |
Current Portion Of Capital Lease Obligations | $4.7M | $6M | $5M | $4.5M | $5.6M | |
Other Current Liabilities | $18.6M | $20M | $24M | $26.6M | $17.3M | |
Total Current Liabilities | $85.9M | $267.3M | $126.7M | $89.1M | $81.8M | |
Long-Term Debt | $156M | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $338.7M | $370.3M | $233.3M | $220.1M | $222.4M | |
Common Stock | $112K | $109K | $108K | $108K | $107K | |
Other Common Equity Adj | -$81K | -$1.5M | -$5M | -$1.3M | -$1.3M | |
Common Equity | $912.7M | $862.4M | $779.3M | $1B | $1.1B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $912.7M | $862.4M | $779.3M | $1B | $1.1B | |
Total Liabilities and Equity | $1.3B | $1.2B | $1B | $1.3B | $1.3B | |
Cash and Short Terms | $502.6M | $485.6M | $313.2M | $425.8M | $481.8M | |
Total Debt | $156M | $163.7M | $10.4M | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $109.6M | $179.1M | $99.9M | $112.6M | $132.2M | |
Short Term Investments | $419.6M | $164.6M | $192.3M | $278.4M | $382.2M | |
Accounts Receivable, Net | $35.9M | $51.2M | $59.4M | $86.9M | $119.1M | |
Inventory | $9.9M | $6.2M | $26.2M | $47.6M | $44.7M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $11.6M | $12.3M | $14.6M | $12.4M | $17.6M | |
Total Current Assets | $724.3M | $545.1M | $492.8M | $576.5M | $719.5M | |
Property Plant And Equipment | $80.9M | $77.7M | $112.1M | $88.9M | $102.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $183.2M | $279.8M | $292M | $286.8M | $286.8M | |
Other Intangibles | $31.9M | $57.6M | $46.9M | $25.5M | $15.3M | |
Other Long-Term Assets | $4.1M | $3.3M | $3.6M | $1.4M | $5.3M | |
Total Assets | $1.2B | $1.1B | $962.6M | $1.2B | $1.4B | |
Accounts Payable | $7.8M | $15.5M | $18.1M | $24.8M | $16.4M | |
Accrued Expenses | $14.1M | $17.4M | $15.9M | $12.7M | $14.2M | |
Current Portion Of Long-Term Debt | -- | $73.9M | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $7M | $5.9M | $4.3M | $4.7M | $5.7M | |
Other Current Liabilities | $17.7M | $14.1M | $21.3M | $20.1M | $14.3M | |
Total Current Liabilities | $80.4M | $168.4M | $96.2M | $82.6M | $70.9M | |
Long-Term Debt | $157.9M | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $326.4M | $267.7M | $200.9M | $217.2M | $219.5M | |
Common Stock | $113K | $110K | $109K | $108K | $107K | |
Other Common Equity Adj | -$133K | -$4.3M | -$3.5M | -$1.9M | -$837K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $909.4M | $793.1M | $761.7M | $991.6M | $1.2B | |
Total Liabilities and Equity | $1.2B | $1.1B | $962.6M | $1.2B | $1.4B | |
Cash and Short Terms | $529.1M | $343.7M | $292.1M | $391.1M | $514.4M | |
Total Debt | $157.9M | $73.9M | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$40.5M | $18.3M | -$14.3M | $333.9M | $179.8M | |
Depreciation & Amoritzation | $48.2M | $44.3M | $47.1M | $48.4M | $42.7M | |
Stock-Based Compensation | $25.8M | $27.5M | $35.6M | $45M | $44.9M | |
Change in Accounts Receivable | $172.3M | $104.7M | $98.1M | -$22.8M | -$34.8M | |
Change in Inventories | -$4.4M | $6.1M | -$12.7M | -$15.3M | -$8.5M | |
Cash From Operations | $185.5M | $209.2M | $230.4M | $195.8M | $230.6M | |
Capital Expenditures | $29.7M | $13.8M | $20.5M | $23.2M | $30.7M | |
Cash Acquisitions | -- | -$97.1M | -$15.9M | $106.3M | -- | |
Cash From Investing | -$97.6M | -$115.7M | $152M | -$57.4M | -$56.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $91.7M | -- | -- | |
Long-Term Debt Repaid | -- | -- | -$258.1M | -$10.4M | -- | |
Repurchase of Common Stock | -$50.1M | -$100.1M | -$100.4M | -$100.5M | -$113.3M | |
Other Financing Activities | -$22.6M | -$23.1M | -$32.8M | -$57M | -$60.1M | |
Cash From Financing | -$61.2M | -$114.2M | -$362.9M | -$169.6M | -$168M | |
Beginning Cash (CF) | $102.5M | $129.3M | $108.3M | $125.7M | $94.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $26.7M | -$20.6M | $19.4M | -$31.2M | $5.9M | |
Ending Cash (CF) | $129.3M | $108.3M | $125.7M | $94.8M | $99.8M | |
Levered Free Cash Flow | $155.7M | $195.4M | $209.9M | $172.5M | $199.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$2.6M | -$66.2M | $3.3M | $32.9M | $60.3M | |
Depreciation & Amoritzation | $10.8M | $10.8M | $12.8M | $11M | $9.8M | |
Stock-Based Compensation | $6.5M | $7.8M | $13.1M | $9.5M | $11.4M | |
Change in Accounts Receivable | $22.7M | $26.3M | $33.5M | $3.7M | -$310K | |
Change in Inventories | $4.5M | $2.3M | -$5.3M | -$11.4M | -$67K | |
Cash From Operations | $39.5M | $42.6M | $38.9M | $39.1M | $77.4M | |
Capital Expenditures | $3.5M | $4.7M | $7.7M | $3M | $7.9M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$48.5M | $204.8M | -$10.7M | $71.4M | -$8.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $72.4M | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$174.5M | -$10.4M | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -$50.8M | -$2.2M | |
Other Financing Activities | -$11.2M | -$19M | -$33.9M | -$41.8M | -$34.6M | |
Cash From Financing | -$10.3M | -$175.9M | -$54.2M | -$92.3M | -$36.8M | |
Beginning Cash (CF) | $129.3M | $108.3M | $125.7M | $94.8M | $99.8M | |
Foreign Exchange Rate Adjustment | -$144K | -$224K | $191K | -$295K | $124K | |
Additions / Reductions | -$19.3M | $71.5M | -$26M | $18.1M | $32.3M | |
Ending Cash (CF) | $109.9M | $179.5M | $99.9M | $112.6M | $132.2M | |
Levered Free Cash Flow | $35.9M | $37.9M | $31.2M | $36.1M | $69.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$36.5M | -$45.3M | $55.2M | $363.5M | $207.2M | |
Depreciation & Amoritzation | $46.6M | $44.3M | $49.1M | $46.6M | $41.6M | |
Stock-Based Compensation | $26.2M | $28.8M | $40.8M | $41.4M | $46.8M | |
Change in Accounts Receivable | $155.9M | $108.3M | $105.2M | -$52.7M | -$38.8M | |
Change in Inventories | -$78K | $3.9M | -$20.3M | -$21.4M | $2.9M | |
Cash From Operations | $187.7M | $212.4M | $226.7M | $196M | $268.9M | |
Capital Expenditures | $31.3M | $15M | $23.5M | $18.5M | $35.6M | |
Cash Acquisitions | -- | -$97.1M | -$15.9M | $106.3M | -- | |
Cash From Investing | -$188.3M | $137.6M | -$63.5M | $24.7M | -$136.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $72.4M | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$174.5M | -$94M | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -$151.3M | -$64.7M | |
Other Financing Activities | -$24M | -$31M | -$47.7M | -$64.8M | -$53M | |
Cash From Financing | -$65.7M | -$279.9M | -$241.2M | -$207.8M | -$112.4M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$66.3M | $70.1M | -$78M | $12.9M | $20M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $156.4M | $197.4M | $203.2M | $177.5M | $233.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$2.6M | -$66.2M | $3.3M | $32.9M | $60.3M | |
Depreciation & Amoritzation | $10.8M | $10.8M | $12.8M | $11M | $9.8M | |
Stock-Based Compensation | $6.5M | $7.8M | $13.1M | $9.5M | $11.4M | |
Change in Accounts Receivable | $22.7M | $26.3M | $33.5M | $3.7M | -$310K | |
Change in Inventories | $4.5M | $2.3M | -$5.3M | -$11.4M | -$67K | |
Cash From Operations | $39.5M | $42.6M | $38.9M | $39.1M | $77.4M | |
Capital Expenditures | $3.5M | $4.7M | $7.7M | $3M | $7.9M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$48.5M | $204.8M | -$10.7M | $71.4M | -$8.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $72.4M | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$174.5M | -$10.4M | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -$50.8M | -$2.2M | |
Other Financing Activities | -$11.2M | -$19M | -$33.9M | -$41.8M | -$34.6M | |
Cash From Financing | -$10.3M | -$175.9M | -$54.2M | -$92.3M | -$36.8M | |
Beginning Cash (CF) | $129.3M | $108.3M | $125.7M | $94.8M | $99.8M | |
Foreign Exchange Rate Adjustment | -$144K | -$224K | $191K | -$295K | $124K | |
Additions / Reductions | -$19.3M | $71.5M | -$26M | $18.1M | $32.3M | |
Ending Cash (CF) | $109.9M | $179.5M | $99.9M | $112.6M | $132.2M | |
Levered Free Cash Flow | $35.9M | $37.9M | $31.2M | $36.1M | $69.5M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.